Shraddha V. Bhadada

812 total citations
18 papers, 642 citations indexed

About

Shraddha V. Bhadada is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shraddha V. Bhadada has authored 18 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shraddha V. Bhadada's work include Protein Tyrosine Phosphatases (3 papers), Natural Antidiabetic Agents Studies (3 papers) and RNA Interference and Gene Delivery (2 papers). Shraddha V. Bhadada is often cited by papers focused on Protein Tyrosine Phosphatases (3 papers), Natural Antidiabetic Agents Studies (3 papers) and RNA Interference and Gene Delivery (2 papers). Shraddha V. Bhadada collaborates with scholars based in India and Saudi Arabia. Shraddha V. Bhadada's co-authors include Bhoomika M. Patel, Bhoomika R. Goyal, Avani Amin, Bhumika Patel, Manjunath Ghate, Vivek K. Vyas, Ramesh K. Goyal, Anita A. Mehta, Chandan Sahi and Chandrabose Karthikeyan and has published in prestigious journals such as European Journal of Neuroscience, European Journal of Pharmacology and BioMed Research International.

In The Last Decade

Shraddha V. Bhadada

18 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shraddha V. Bhadada India 11 269 114 77 75 69 18 642
Bhoomika R. Goyal India 9 232 0.9× 116 1.0× 77 1.0× 65 0.9× 70 1.0× 14 673
Marcella Bonanomi Italy 15 318 1.2× 50 0.4× 90 1.2× 7 0.1× 81 1.2× 29 618
Chenjuan Yao Japan 22 584 2.2× 14 0.1× 80 1.0× 28 0.4× 198 2.9× 55 1.1k
Dongfang Qiao China 15 256 1.0× 58 0.5× 205 2.7× 15 0.2× 48 0.7× 42 755
Fangchao Wei China 7 197 0.7× 20 0.2× 97 1.3× 53 0.7× 137 2.0× 10 551
Margaret E. Kargacin Canada 16 535 2.0× 36 0.3× 20 0.3× 25 0.3× 88 1.3× 30 837
Xiangkun Yang United States 15 432 1.6× 67 0.6× 25 0.3× 10 0.1× 23 0.3× 22 663
Carolina Martínez Argentina 14 170 0.6× 68 0.6× 13 0.2× 79 1.1× 79 1.1× 34 560
Wen-Yu Cheng Taiwan 17 344 1.3× 37 0.3× 12 0.2× 36 0.5× 22 0.3× 48 869

Countries citing papers authored by Shraddha V. Bhadada

Since Specialization
Citations

This map shows the geographic impact of Shraddha V. Bhadada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shraddha V. Bhadada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shraddha V. Bhadada more than expected).

Fields of papers citing papers by Shraddha V. Bhadada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shraddha V. Bhadada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shraddha V. Bhadada. The network helps show where Shraddha V. Bhadada may publish in the future.

Co-authorship network of co-authors of Shraddha V. Bhadada

This figure shows the co-authorship network connecting the top 25 collaborators of Shraddha V. Bhadada. A scholar is included among the top collaborators of Shraddha V. Bhadada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shraddha V. Bhadada. Shraddha V. Bhadada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chavda, Vishal, et al.. (2021). Pre‐exposure of voglibose exerts cerebroprotective effects through attenuating activation of the polyol pathway and inflammation. European Journal of Neuroscience. 53(8). 2541–2552. 3 indexed citations
2.
Karthikeyan, Chandrabose, et al.. (2020). Virtual Screening Based Discovery of PTP1B Inhibitors and Their Biological Evaluations. Letters in Drug Design & Discovery. 18(2). 121–130. 1 indexed citations
3.
4.
Karthikeyan, Chandrabose, et al.. (2019). Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors. Bioorganic Chemistry. 92. 103221–103221. 21 indexed citations
6.
Patel, Bhumika, Shraddha V. Bhadada, & Manjunath Ghate. (2017). Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors. Bioorganic Chemistry. 72. 345–358. 49 indexed citations
7.
Bhadada, Shraddha V., Vivek K. Vyas, & Ramesh K. Goyal. (2016). Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity. Biomedicine & Pharmacotherapy. 83. 221–228. 26 indexed citations
8.
Bhadada, Shraddha V. & Ramesh K. Goyal. (2016). Effect of flavonoid rich fraction of Tephrosiapurpurea (Linn.) Pers. on complications associated with streptozotocin-induced type I diabetes mellitus.. PubMed. 54(7). 457–466. 7 indexed citations
9.
Bhadada, Shraddha V., et al.. (2015). Preventive Effect ofTephrosia purpureaon Selenite-Induced Experimental Cataract. Current Eye Research. 41(2). 222–231. 16 indexed citations
10.
Bhadada, Shraddha V., et al.. (2014). Evaluation of Buspirone on Streptozotocin Induced Type 1 Diabetes and Its Associated Complications. BioMed Research International. 2014. 1–9. 27 indexed citations
11.
Patel, Bhoomika M. & Shraddha V. Bhadada. (2013). Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril. Clinical and Experimental Hypertension. 36(5). 340–347. 16 indexed citations
13.
Bhadada, Shraddha V., et al.. (2011). Investigation of the potential effects of metformin on atherothrombotic risk factors in hyperlipidemic rats. European Journal of Pharmacology. 659(2-3). 213–223. 24 indexed citations
14.
Bhadada, Shraddha V., et al.. (2011). β3Receptors: role in cardiometabolic disorders. Therapeutic Advances in Endocrinology and Metabolism. 2(2). 65–79. 26 indexed citations
15.
Bhadada, Shraddha V., Bhoomika R. Goyal, & Bhoomika M. Patel. (2010). Angiogenic targets for potential disorders. Fundamental and Clinical Pharmacology. 25(1). 29–47. 55 indexed citations
16.
Goyal, Bhoomika R., et al.. (2009). Therapeutic opportunities of small interfering RNA. Fundamental and Clinical Pharmacology. 23(4). 367–386. 10 indexed citations
17.
Patel, Bhoomika M., et al.. (2008). Getting into the Brain. CNS Drugs. 23(1). 35–58. 337 indexed citations
18.
Bhadada, Shraddha V. & Ramesh K. Goyal. (2007). Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats. Canadian Journal of Physiology and Pharmacology. 85(8). 831–836. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026